Tag: drug

Shares of the New York-based company jumped nearly 20 percent Tuesday on news that the REGENERATE study of obeticholic acid showed strong improvement in NASH-related liver fibrosis. Source link
British drugmaker AstraZeneca has dropped two Phase III clinical trials of its approved immuno-oncology drug following the studies’ failure late last year. In its fourth quarter earnings Thursday, the London-based pharmaceutical giant said it had removed the EAGLE and MYSTIC studies. The Phase III trials test the approved PD-L1...
graphic design of a liver
A closely watched Phase III study of a Gilead Sciences drug for nonalcoholic steatohepatitis has failed. The Foster City, California-based drugmaker said Monday that the STELLAR-4 trial of selonsertib in patients with compensated cirrhosis – also known as F4 fibrosis – due to NASH did not meet the primary...
A new study has found that while drugmakers benefit in various ways when a product candidate receives Breakthrough Therapy Designation from the Food and Drug Administration, it seems to carry little weight with investors. The researchers found that while companies with no products on the market may experience a...
Money pile and medicine pills representing medical expenses
Of the many policy ideas in the Trump administration’s “blueprint” for lowering drug prices, one that got a significant amount of attention was a proposed requirement to have televised drug advertisements carry the list prices of drugs. Now, one of the largest drugmakers in the country has decided...
Through the Splunk controlled substance monitoring platform, NewYork-Presbyterian can see if medications are being diverted for potentially illegitimate purposes, like a doctor prescribing a medication to a patient not currently in the hospital. Source link
A similar drug, Janssen’s Darzalex, has already been on the market since 2014 and become well-established, with more than $1 billion in global sales last year. Source link
U.S. Health and Human Services Secretary Alex Azar threw the healthcare industry for a loop last week after unveiling a long-awaited proposal to ban the rebate deals struck between drug-makers and PBMs for Medicare and managed Medicaid prescription drug plans. The proposal eliminates any kickbacks or rebates pharma companies...
The Food and Drug Administration turned down a drug for depression that had previously received a negative opinion from a panel of experts the agency convened to review the developer’s application. Dublin-based Alkermes said Friday that it received a complete response letter from the agency for its drug, ALKS...
A proposal by the Trump administration to address the high prices of drugs by making drugmakers include list price information in direct-to-consumer advertising received renewed attention in Congress this week. But while a recent study indicates that high list prices can indeed diminish interest in a drug, it...
0FansLike
0FollowersFollow

Latest Posts